VANCOUVER, British Columbia, Nov. 18, 2017 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”), an emerging-stage pharmaceutical and IP development company, is pleased to announce that it has signed a Binding Letter of Intent with … Read More
The post Veritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing … appeared first on Dagga Magazine.